Skip to main content
. 2022 Apr 18;49(11):3917–3928. doi: 10.1007/s00259-022-05787-9

Table 4.

Contingency’s tables for PSMA SUVmax and ADCmean

EXP growth INF growth
PSMA SUVmax < 13.0 6/62 30/62
PSMA SUVmax > 13.0 19/62 7/62
ADCmean < 0.955 25/62 12/62
ADCmean > 0.955 0/62 25/62

EXP, expansive; INF, infiltrative; PSMA, prostate-specific membrane antigen; SUV, standardized uptake value; max, maximum; ADC, apparent diffusion coefficient